Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Bichet

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
The Journal of Clinical Investigation|September 1, 1993
X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesisD G Bichet, M F Arthus, M Lonergan, et al.
Molecular Genetics and Metabolism|March 12, 2013
A Phase 2 study of migalastat hydrochloride in females with Fabry disease: selection of population, safety and pharmacodynamic effectsR Giugliani, S Waldek, D P Germain, et al.
American Journal of Human Genetics|September 6, 2001
Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminusM Kuwahara, K Iwai, T Ooeda, et al.
The Journal of Clinical Investigation|July 3, 1998
An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complexS M Mulders, D G Bichet, J P Rijss, et al.
Journal of the American Society of Nephrology : JASN|October 17, 1998
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotypeY Ala, D Morin, B Mouillac, et al.
Molecular Genetics and Metabolism|March 1, 2021
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensusD Moreno-Martinez, P Aguiar, C Auray-Blais, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
The Journal of Clinical Investigation|September 1, 1993
X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesisD G Bichet, M F Arthus, M Lonergan, et al.
Molecular Genetics and Metabolism|March 12, 2013
A Phase 2 study of migalastat hydrochloride in females with Fabry disease: selection of population, safety and pharmacodynamic effectsR Giugliani, S Waldek, D P Germain, et al.
American Journal of Human Genetics|September 6, 2001
Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminusM Kuwahara, K Iwai, T Ooeda, et al.
The Journal of Clinical Investigation|July 3, 1998
An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complexS M Mulders, D G Bichet, J P Rijss, et al.
Journal of the American Society of Nephrology : JASN|October 17, 1998
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotypeY Ala, D Morin, B Mouillac, et al.
Molecular Genetics and Metabolism|March 1, 2021
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensusD Moreno-Martinez, P Aguiar, C Auray-Blais, et al.
Pageof 8